Genetic Technologies Ltd.
GENE
GENE was delisted on the 16th of October, 2024.
10 hedge funds and large institutions have $1.33M invested in Genetic Technologies Ltd. in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 6 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
20% less capital invested
Capital invested by funds: $1.65M → $1.33M (-$322K)
41% less funds holding
Funds holding: 17 → 10 (-7)
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$39.2K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$367 |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$317 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$48K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$41.4K |
| 3 |
AGM
Alpine Global Management
New York
|
-$38K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$23K |
| 5 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
-$7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $841K | +$39.2K | +2,355 | +5% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $418K | -$41.4K | -2,484 | -9% |
|
|
3
Bank of America
Charlotte,
North Carolina
| $52K | +$367 | +22 | +0.7% |
|
|
4
UBS Group
Zurich,
Switzerland
| $10K | +$317 | +19 | +3% |
|
|
CG
5
Cutler Group
San Francisco,
California
| $3K | – | – | – |
|
|
LTFS
6
Ladenburg Thalmann Financial Services
Miami,
Florida
| $2K | – | – | – |
|
7
Morgan Stanley
New York
| $1K | – | – | – |
|
|
RE
8
RBC Europe
London,
United Kingdom
| $68 | +$67 | +4 | New |
|
|
SM
9
Sabby Management
Miami Beach,
Florida
| – | -$48K | -2,681 | Closed |
|
|
AGM
10
Alpine Global Management
New York
| – | -$38K | -2,111 | Closed |
|
|
11
Citadel Advisors
Miami,
Florida
| – | -$23K | -1,279 | Closed |
|
|
AIM
12
Acrospire Investment Management
Chicago,
Illinois
| – | -$7K | -361 | Closed |
|
GENE Hedge Fund Activity: Q3 2017 in Review
10 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Genetic Technologies Ltd. (GENE) for Q3 2017, worth a combined $1.33M — down 20% from $1.65M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of GENE and 1 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 3 added.
The largest buyer was Renaissance Technologies, adding an estimated $39.2K. The largest seller was Sabby Management, exiting entirely with an estimated $48K sold.
- 10 institutional investors held Genetic Technologies Ltd. (GENE) as of Q3 2017, down from 17 in Q2 2017.
- Funds reported $1.33M of Genetic Technologies Ltd. stock for Q3 2017, down 20% quarter-over-quarter.
- 1 fund opened new Genetic Technologies Ltd. positions in Q3 2017 and 6 closed out, a net change of -5 holders.
- The largest Genetic Technologies Ltd. buyer in Q3 2017 was Renaissance Technologies, an estimated $39.2K added.
- The largest Genetic Technologies Ltd. seller in Q3 2017 was Sabby Management, an estimated $48K sold.
Based on aggregated 13F filings for Q3 2017.